,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-01-19 06:30:00,"Chicago, IL - January 19, 2017, 2016 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.01457957923412323,0.012257915921509266,0.9731624722480774,neutral,0.002321663312613964
1,2017-01-19 06:30:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2017-01-19 06:30:00,"Stocks recently featured in the blog include ExxonMobil (NYSE: XOM - Free Report ), Procter & Gamble (NYSE: PG - Free Report ), Micron (NASDAQ: MU - Free Report ), Macy's (NYSE: M - Free Report ) and Alexion Pharmaceuticals (NASDAQ: ALXN - Free Report ).",0.020927811041474342,0.011428291909396648,0.9676439762115479,neutral,0.009499519132077694
3,2017-01-19 06:30:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
4,2017-01-19 06:30:00,Get #1Stock of the Day pick for free.,0.0864095613360405,0.03249066323041916,0.8810997605323792,neutral,0.05391889810562134
5,2017-01-19 06:30:00,"Here are highlights from Wednesday's Analyst Blog:

We have featured 16 research reports in today's Research Daily, including reports on ExxonMobil (NYSE: XOM - Free Report ) and Procter & Gamble (NYSE: PG - Free Report ).",0.017059458419680595,0.010075516067445278,0.9728649854660034,neutral,0.006983942352235317
6,2017-01-19 06:30:00,These reports have been hand-picked from among the 70 or so reports issued by our research team today.,0.059226009994745255,0.006372051779180765,0.9344018697738647,neutral,0.05285395681858063
7,2017-01-19 06:30:00,"You can see all of today's research reports here >>>

A brief comment on the ongoing Q4 earnings season is in order here.",0.014172526076436043,0.011192060075700283,0.9746354222297668,neutral,0.0029804660007357597
8,2017-01-19 06:30:00,"Including this morning's results from Goldman Sachs, Citigroup and others, we now have Q4 results from 41 S&P 500 members that combined account for 12.5% of the index's total market capitalization.",0.06602194905281067,0.007560628931969404,0.9264174103736877,neutral,0.05846131965517998
9,2017-01-19 06:30:00,"Total earnings for these companies are up +11.3% from the same period last year on +3.9% higher revenues, with 70.7% beating EPS estimates and 46.3% beating revenue estimates.",0.9582008719444275,0.023263543844223022,0.018535476177930832,positive,0.9349373579025269
10,2017-01-19 06:30:00,"Relative to what we have seen from the same group of 41 index members in other recent periods, the earnings growth is tracking higher, revenue growth is about in-line and positive surprises for both earnings and revenues are below historical periods.",0.9281928539276123,0.02489832043647766,0.04690883308649063,positive,0.903294563293457
11,2017-01-19 06:30:00,"ExxonMobil shares tracked the S&P 500 index through year-end 2016, but have lagged the broader index as well as the peer super majors group in the year-to-date period, likely reflecting the company's perceived defensiveness that disadvantages it relative to its 'oilier' peers.",0.04096486046910286,0.9371024966239929,0.021932639181613922,negative,-0.8961376547813416
12,2017-01-19 06:30:00,"Exxon's resilient integrated business model has long been the industry gold standard, which makes it an attractive and relatively low-risk Energy sector option for many investors.",0.8528649210929871,0.012427650392055511,0.13470739126205444,positive,0.8404372930526733
13,2017-01-19 06:30:00,"A fortress balance sheet, an attractive and totally safe dividend and a history of returning excess cash to shareholders are some of the other positives in the Exxon story.",0.7404021620750427,0.015704702585935593,0.243893101811409,positive,0.724697470664978
14,2017-01-19 06:30:00,The Zacks analyst discusses the pros & cons of investing in Exxon shares in the updated research report issued today.,0.030629536136984825,0.006549749989062548,0.9628207087516785,neutral,0.024079786613583565
15,2017-01-19 06:30:00,"(You can read the full research report on ExxonMobil here >> )

Procter & Gamble shares outperformed the Zacks Consumer Staples sector in the past year (+11.1% vs. +6.3%) on the back of strong organic sales (up +3% in Q3) and improving margins as a result of productivity gains and cost-saving efforts.",0.9597501754760742,0.017130490392446518,0.02311939187347889,positive,0.9426196813583374
16,2017-01-19 06:30:00,"On the flip side, the Zacks analyst points to mature end markets and the negative impact of the strong U.S. dollar as some of the headwinds for the stock.",0.0938594713807106,0.6864146590232849,0.21972578763961792,negative,-0.5925551652908325
17,2017-01-19 06:30:00,"The stock was up following the last quarterly release, so it will be interesting to see how it performs in response to January 20th earnings report.",0.4241526424884796,0.018406549468636513,0.5574408173561096,neutral,0.40574610233306885
18,2017-01-19 06:30:00,P&G shares have moved roughly in-line with the S&P 500 index in the year-to-date period.,0.7879571914672852,0.043287746608257294,0.16875512897968292,positive,0.7446694374084473
19,2017-01-19 06:30:00,"(You can read the full research report on Procter & Gamble here >> )

Other noteworthy reports we are featuring today include Micron (NASDAQ: MU - Free Report ), Macy's (NYSE: M - Free Report ) and Alexion Pharmaceuticals (NASDAQ: ALXN - Free Report ).",0.01337387040257454,0.010625720024108887,0.9760003685951233,neutral,0.0027481503784656525
20,2017-01-19 06:30:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
21,2017-01-19 06:30:00,Get #1 Stock of the Day pick for free .,0.2226315140724182,0.024793583899736404,0.7525749206542969,neutral,0.1978379338979721
22,2017-01-19 06:30:00,Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.,0.06386703997850418,0.004654404241591692,0.9314785599708557,neutral,0.059212636202573776
23,2017-01-19 06:30:00,"Continuous coverage is provided for a universe of 1,150 publicly traded stocks.",0.036364275962114334,0.004866600502282381,0.9587691426277161,neutral,0.03149767592549324
24,2017-01-19 06:30:00,Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance.,0.054108913987874985,0.005191051866859198,0.9407000541687012,neutral,0.04891786351799965
25,2017-01-19 06:30:00,Recommendations and target prices are six-month time horizons.,0.013092893175780773,0.007127966266125441,0.9797791242599487,neutral,0.0059649269096553326
26,2017-01-19 06:30:00,"Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar.",0.044983625411987305,0.5624399185180664,0.3925764560699463,negative,-0.5174562931060791
27,2017-01-19 06:30:00,They're virtually unknown to the general public.,0.035764459520578384,0.0785161554813385,0.885719358921051,neutral,-0.04275169596076012
28,2017-01-19 06:30:00,"Yet today's 220 Zacks Rank #1 ""Strong Buys"" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015.",0.6580293774604797,0.017276067286729813,0.32469451427459717,positive,0.6407533288002014
29,2017-01-19 06:30:00,Its average gain has been a stellar +26% per year.,0.8422174453735352,0.0191669799387455,0.13861553370952606,positive,0.8230504393577576
30,2017-01-19 06:30:00,See these high-potential stocks free >>.,0.12527841329574585,0.05778927728533745,0.8169323205947876,neutral,0.0674891322851181
31,2017-01-19 06:30:00,"Get the full Report on XOM - FREE

Get the full Report on PG - FREE

Get the full Report on MU - FREE

Get the full Report on M - FREE

Get the full Report on ALXN - FREE

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.013513484969735146,0.009815015830099583,0.9766715168952942,neutral,0.003698469139635563
32,2017-01-19 06:30:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
33,2017-01-19 06:30:00,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
34,2017-01-19 06:30:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
35,2017-01-19 06:30:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
36,2017-01-19 06:30:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
37,2017-01-19 06:30:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
38,2017-01-19 06:30:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
39,2017-01-19 06:30:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
40,2017-01-19 06:30:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
41,2017-01-19 06:30:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
42,2017-01-19 06:30:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
43,2017-01-19 06:30:00,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
44,2017-01-19 06:30:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
45,2017-01-19 06:30:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069374665617943,0.007019795011729002,0.9422864317893982,neutral,0.04367395117878914
46,2017-01-19 06:30:00,"Click to get this free report

To read this article on Zacks.com click here.",0.02068457007408142,0.033159855753183365,0.9461556077003479,neutral,-0.012475285679101944
47,2017-01-19 06:30:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
